Other languages MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Market Closed - Canadian Securities Exchange Other stock markets 12:39:47 01/05/2024 am IST			5-day change	1st Jan Change
0.035 ^CAD	+16.67%		+16.67%	-12.50%

21/03	MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI
04/03	MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	21/03
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	05/03
MYND Life Sciences Inc. Appoints Laurie Bakke as an Independent Non-Executive Director	31/01
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. to Executive Chairman from the Role of CEO	06/12
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. from the Role of CEO to Executive Chairman	06/12
MYND Life Sciences Inc. Appoints Mr. John Campbell as Chief Executive Officer	06/12
MYND Life Sciences Inc. Appoints John Campbell as President	06/12
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	20/23/20
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	29/23/29
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	06/23/06
MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	28/23/28
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	28/23/28
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	28/22/28
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.	29/22/29
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	23/22/23
MYND Life Sciences Inc. Announces New Testing Methodologies for Measuring Cellular Responses to Microdosing with Psilocybins	01/22/01
MYND Lifesciencs Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022	01/22/01
MYND Lifesciencs Inc. Hires Chaahat S.B Singh as Senior Operations and Research Manager	09/22/09
MYND Lifesciencs Inc. Auditor Raises 'Going Concern' Doubt	28/22/28
MYND Lifesciencs Inc. Reports Earnings Results for the Full Year Ended October 31, 2021	28/22/28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Other languages

Filters